A Randomized, Open-label, Active-controlled, Phase 2a Clinical Trial to Evaluate the Efficacy and Safety of TFC-003 in Patients With Primary Open-angle Glaucoma or Ocular Hypertension

Clinical trial NCT06177678 · UNKNOWN

Trial details

NCT number: NCT06177678
Sponsor: Kukje Pharma
Status: UNKNOWN
Phase: Phase 2
Study type: INTERVENTIONAL

Primary Open Angle Glaucoma Ocular Hypertension

Start date: 2024-02-01
Primary completion: 2024-09-01
Enrollment: 60

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.